PB2019: EFFICACY AND SAFETY OF IXAZOMIB PLUS LENALIDOMIDE AND DEXAMETHASONE FOLLOWING INJECTABLE PROTEASOME INHIBITOR-BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Sasaki, M., Suzuki, K., Abe, Y., Ito, S., Nishiwaki, K., Handa, H., Chou, T., Soeda, J., Mori, I., Shinozaki, T., Takezako, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431417/
http://dx.doi.org/10.1097/01.HS9.0000850908.45753.c0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431417/
http://dx.doi.org/10.1097/01.HS9.0000850908.45753.c0

Ejemplares similares